PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Roche Products Ltd
RP

Roche Products Ltd

Welwyn Garden City
Large

Roche Products Ltd focuses on developing tests and treatments for serious diseases, including pharmaceuticals and diagnostic solutions. They aim to improve patient outcomes through scientific innovation and partnerships.

roche.co.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£2.6bn
Live
77
Buyers
17
12m
£2.1bn
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities6
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts77 / 117
  • Top buyers17
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Roche Products LtdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Roche Products Ltd has won £2.6bn across 17 public-sector buyers, with 77 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 73% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
77 of 117Live contracts
73%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
Environment1 commitment ↗✓
Tackling inequalityNo commitment stated✓
CommunityNo commitment stated✓
Environment · 1
  • WebsiteSustainabilityRoche contributes to improving outcomes for patients through transformative medicines and diagnostic solutions.

Extracted automatically from roche.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 2
Pharmaceutical SolutionsDevelopment and availability of treatments for serious diseases. ↗Diagnostic SolutionsDevelopment of diagnostic tests, instruments, and digital solutions for healthcare professionals. ↗
Frameworks & DPS · 6 from notices
  • NHS Framework Agreement for Trastuzumab InjectionNHS England · £56.7m
  • NHS National Framework Agreement for the supply of products for the treatment of Haemophilia ANHS England · £37.2m
  • NHS England Framework Agreement: South of England (Tranche B)NHS England · £15.7m
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS England Framework Agreement - London - Tranche ANHS England · £10.6m
  • NHS Framework Agreement for Proprietary Pharmaceuticals - South of England (Tranche A)NHS England · £10.5m

Extracted automatically from roche.co.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 77 live · 40 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Transitional Drugs 7
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Jul 2026£16.8m2 yrspending
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS England—01 Sept 2026£813.9m2 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Framework for the supply of Tocilizumab Injection
NHS England—01 Mar 2026£150.1m1.5 yrspending
Baloxavir Marboxil Xofluza Antiviral
UK HEALTH AND SECURITY AGENCY—01 Nov 2025£112 mopending
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
NHS England North East and Yorkshire Health and Justice—01 Dec 2025£688.8m1.5 yrspending
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
NHS England3360000001 Sept 2025£47.0m2 yrsLive
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
NHS England3360000001 Sept 2025£9.4m2 yrsLive
NHS Branded Medicines Tranche Framework for London and South of England
NHS England3360000001 Sept 2024£13.1m2 yrsLive
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024
NHS England3360000001 May 2024£11.2m4 yrsLive
Total live value £98.3m · mean award £22.2m1–10 of 117

Top buyers · 17 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
63 contracts
73%
since 2017
2
NHS England North East and Yorkshire Health and Justice
1 contract
27%
since 2025
3
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
1 contract
1%
since 2026
4
NHS England and NHS Improvement
1 contract
0%
since 2022
5
UK HEALTH AND SECURITY AGENCY
2 contracts
0%
since 2025
6
Business Energy and Industrial Strategy
2 contracts
0%
since 2021
7
Department of Health and Social Care (T&T)
1 contract
0%
since 2018
8
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
25 contracts
0%
9
eTenderwales
2 contracts
0%
10
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
7 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire65 contracts
99%
Wales10 contracts
1%
London3 contracts
0%
Scotland25 contracts
0%
Northern Ireland5 contracts
0%
North West6 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Roche Products Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
RP
Roche Products Ltd
No£2.1bn—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 13 May 2027
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
00100674
Status
Active
Type
Private limited
Incorporated
14 Dec 1908
Reg. office
6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW
SIC codes
46460 · 72190
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • PAMBA, Allan, Dr — director
    Appointed 21 Apr 2026
  • ROWBOTHAM, Kathryn — director
    Appointed 11 Aug 2025
  • DAVIS, Scott — director
    Appointed 27 Jan 2025
  • LOEWENSTEIN, Danielle Lisa — director
    Appointed 27 Jan 2025
  • FERRARO, Robert — director
    Appointed 11 Jul 2022
  • DAVIS, Scott — secretary
    Appointed 13 Mar 2019
  • Roche Holding (Uk) Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
ROCHE PRODUCTS LIMITED
00100674 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.